Sysmex Corporation

Research Sysmex Corporation (0YX) on Bullrun: valuation model: 3.8% overvalued, market cap EUR 4.36B, P/E 22.9, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker0YX
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Valuation signal3.8% overvalued
• Market capEUR 4.36B
• P/E22.9
• Dividend yield3.1%
• Financial periodFY2025
• RevenueEUR 508.64B
• Revenue growth10.2%
• Net incomeEUR 53.67B
• Free cash flowEUR 38.29B
• Gross margin53.5%

Valuation Snapshot

Bullrun's latest valuation model marks Sysmex Corporation as 3.8% overvalued; latest market cap is EUR 4.36B; P/E is 22.9; dividend yield is 3.1%.

About Sysmex Corporation

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers;

Frequently asked questions

Is Sysmex Corporation overvalued or undervalued?

Bullrun's valuation model currently marks Sysmex Corporation as 3.8% overvalued.

What is Sysmex Corporation's market cap?

Sysmex Corporation's market capitalization is EUR 4.36B.

What is Sysmex Corporation's P/E ratio?

Sysmex Corporation's price-to-earnings (P/E) ratio is 22.9.

Does Sysmex Corporation pay a dividend?

Sysmex Corporation has a dividend yield of 3.1%.

What does Sysmex Corporation do?

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software.